Clinofibrate is a fibrate class medication primarily utilized to treat hyperlipidemia by reducing serum triglyceride and LDL cholesterol levels while simultaneously increasing HDL cholesterol. It functions… Read more
Clinofibrate is a fibrate class medication primarily utilized to treat hyperlipidemia by reducing serum triglyceride and LDL cholesterol levels while simultaneously increasing HDL cholesterol. It functions as a peroxisome proliferator-activated receptor alpha (PPAR-alpha) agonist, facilitating the clearance of triglyceride-rich lipoproteins from the bloodstream. This category features high-quality Clinofibrate reference standards, including associated impurities and metabolites, which are essential for rigorous analytical testing and pharmaceutical quality control. Laboratories rely on these materials for detailed impurity profiling, ensuring that drug substances meet established regulatory safety and efficacy standards. By using these characterized compounds, researchers can accurately perform method validation, identify degradation products, and monitor manufacturing by-products. The inclusion of stable isotope labelled compounds further supports precise quantification in complex biological matrices, facilitating robust pharmaceutical development and consistent batch-to-batch monitoring throughout the entire product lifecycle.